Jul 30, 2014, 00:00
by
Michael Croft
PITTSBURGH, PA - Jul 30, 2014 - Avere Systems, a leading provider of enterprise storage for the hybrid cloud, today announced that the Inova Translational Medicine Institute (ITMI) has chosen Avere for access to the worlds largest, centralized repository of whole genome sequence data
Hybrid Cloud Solution Connects Local
Storage to the Cloud
PITTSBURGH, PA - Jul 30, 2014 - Avere Systems, a leading
provider of enterprise storage for the hybrid cloud, today
announced that the
Inova Translational Medicine Institute (ITMI) has chosen Avere
for access to the worlds largest, centralized repository of whole
genome sequence data. ITMI, a research and development arm of Inova
Health System, will use Averes FXT Series Edge Filers with
FlashMove software to move data into and out of the Amazon Simple
Storage Service (Amazon S3). This solution will allow Inova to
build its database with unlimited capacity scaling in the cloud
while lowering the cost of data storage.
Inova Translational Medicine Institute's storage infrastructure
is comprised of world class SGI HPC storage, traditional
on-premises NAS filers, and Amazon's S3 and Glacier services.
Avere's approach and vision for hybrid cloud storage aligns
perfectly with our integrated environment and we see their
solutions as the glue that allows us to tie together disparate
systems and treat the cloud as an on-premise data center, without
the maintenance overhead, said Greg Eley, CTO at Inova
Translational Medicine Institute.
ITMIs mission is to use genetic information to effectively
manage or even prevent conditions such as cancer, heart disease,
stroke and diabetes. Averes hybrid cloud framework will provide
ITMI with a highly available, secure and scalable data storage
solution for managing its database of 5000 complete whole genome
sequences. In addition, Averes FlashMove software enables the
flexibility and agility for ITMI to migrate massive amounts of data
without disruption, supporting the organizations goal of adding
20,000 whole genome sequences over the next two years.
ITMI is changing the face of health care through predictive
modeling, innovative genome research and a pioneering approach to
personalized medicine, said Ron Bianchini, president and CEO of
Avere Systems. As ITMI progresses toward its goal of assembling
the worlds largest whole genome sequence database, Avere is
excited to be a crucial partner in supporting the databases
exponential growth.